Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

A

Membership required to view content.
issued Friday by the Congressional Research Service (CRS) provides a broad overview of the development of the hemp industry, specifically floral hemp and its associated extracts like CBD. 

The report highlights the role of the FDA in the emerging hemp industry, and its failure to create a regulatory pathway for CBD.  It noted that after years of review by a high-level internal working group, the FDA announced in January it would work with Congress to create a new regulatory pathway for CBD. 

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

05.10.2024

2024 RIN Dashboard April Edition

2024 RIN Dashboard April Edition

Renewable Identification Number (RIN) generation has been strong during the first quarter of 2024. The original 2024 mandate was based on fuel assumptions that have since changed. ...

05.10.2024

UCO tariff rumors spark bullish sentiment; traded volume quiet

UCO tariff rumors spark bullish sentiment; traded volume quiet

Distiller’s corn oil (DCO) traded higher at 43 cents per lb delivered Manly, Iowa on Friday May 10, with trading also done at 41.5 cents per lb FOB Missouri...

05.10.2024

Animal proteins steady to lower week on week; WASDE forecasts lower production year on year

Animal proteins steady to lower week on week; WASDE forecasts lower production year on year

US animal proteins were steady to lower week on week for the week to Friday May 10. Only light trade was reported for the second half of the week,...

Latest Tweets